Rocket Pharmaceuticals SG&A Expense (TTM) Insights

Rocket Pharmaceuticals Inc (RCKT)

16.41 +0.35 (+2.18%) USD | NASDAQ | Oct 04, 16:00

16.41 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
June 30, 2024	89.64M
March 31, 2024	79.64M
December 31, 2023	73.32M
September 30, 2023	70.83M
June 30, 2023	67.35M
March 31, 2023	62.83M
December 31, 2022	58.77M
September 30, 2022	51.04M
June 30, 2022	45.96M
March 31, 2022	42.63M
December 31, 2021	41.77M
September 30, 2021	39.60M
June 30, 2021	35.31M
March 31, 2021	32.62M
December 31, 2020	28.87M
September 30, 2020	25.42M
June 30, 2020	24.02M
March 31, 2020	21.60M
December 31, 2019	18.24M
September 30, 2019	15.41M

Date	Value
June 30, 2019	13.34M
March 31, 2019	13.04M
December 31, 2018	17.90M
September 30, 2018	24.46M
June 30, 2018	24.02M
March 31, 2018	20.62M
December 31, 2017	12.54M
September 30, 2017	5.864M
June 30, 2017	6.344M
March 31, 2017	7.957M
December 31, 2016	9.894M
September 30, 2016	9.457M
June 30, 2016	8.971M
March 31, 2016	8.384M
December 31, 2015	7.842M
September 30, 2015	6.308M
June 30, 2015	5.326M
March 31, 2015	3.93M
December 31, 2014	2.112M
September 30, 2014	1.419M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

18.24M

Minimum

Dec 2019

89.64M

Maximum

Jun 2024

47.87M

Average

42.63M

Median

Mar 2022

SG&A Expense (TTM) Benchmarks